TY - JOUR
T1 - Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1
AU - Trompier, Doriane
AU - Chang, Xiu Bao
AU - Barattin, Régis
AU - Du Moulinet D'Hardemare, Amaury
AU - Di Pietro, Attilio
AU - Baubichon-Cortay, Hélène
PY - 2004/7/15
Y1 - 2004/7/15
N2 - This study demonstrates that verapamil and a newly synthesized verapamil derivative, NMeOHI2, behave as apoptogens in multidrug resistance protein 1 (MRP1)-expressing cells. When treated with either verapamil or NMeOHI2, surprisingly, baby hamster kidney-21 (BHK) cells transfected with human MRP1 were killed. Because parental BHK cells were not, as well as cells expressing an inactive (K1333L) MRP1 mutant, this indicated that cell death involved functional MRP1 transporter. Cell death was identified as apoptosis by using annexin V-fluorescein labeling and was no longer observed in the presence of the caspase inhibitor Z-Val-Ala-Asp(OMe)-CH2F (Z-VAD-FMK). In vitro, both verapamil and its derivative inhibited leukotriene C4 transport by MRP1-enriched membrane vesicles in a competitive manner, with a Ki of 48.6 μM for verapamil and 5.5 μM for NMeOHI2, and stimulated reduced glutathione (GSH) transport 3-fold and 9-fold, respectively. Treatment of MRP1-expressing cells with either verapamil or the derivative quickly depleted intracellular GSH content with a strong decrease occurring in the first hour of treatment, which preceded cell death beginning at 8-16 h. Furthermore, addition of GSH to the media efficiently prevented cell death. Therefore, verapamil and its derivative trigger apoptosis through stimulation of GSH extrusion mediated by MRP1. This new information on the mechanism of induced apoptosis of MDR cells may represent a novel approach in the selective treatment of MRP1-positive tumors.
AB - This study demonstrates that verapamil and a newly synthesized verapamil derivative, NMeOHI2, behave as apoptogens in multidrug resistance protein 1 (MRP1)-expressing cells. When treated with either verapamil or NMeOHI2, surprisingly, baby hamster kidney-21 (BHK) cells transfected with human MRP1 were killed. Because parental BHK cells were not, as well as cells expressing an inactive (K1333L) MRP1 mutant, this indicated that cell death involved functional MRP1 transporter. Cell death was identified as apoptosis by using annexin V-fluorescein labeling and was no longer observed in the presence of the caspase inhibitor Z-Val-Ala-Asp(OMe)-CH2F (Z-VAD-FMK). In vitro, both verapamil and its derivative inhibited leukotriene C4 transport by MRP1-enriched membrane vesicles in a competitive manner, with a Ki of 48.6 μM for verapamil and 5.5 μM for NMeOHI2, and stimulated reduced glutathione (GSH) transport 3-fold and 9-fold, respectively. Treatment of MRP1-expressing cells with either verapamil or the derivative quickly depleted intracellular GSH content with a strong decrease occurring in the first hour of treatment, which preceded cell death beginning at 8-16 h. Furthermore, addition of GSH to the media efficiently prevented cell death. Therefore, verapamil and its derivative trigger apoptosis through stimulation of GSH extrusion mediated by MRP1. This new information on the mechanism of induced apoptosis of MDR cells may represent a novel approach in the selective treatment of MRP1-positive tumors.
UR - http://www.scopus.com/inward/record.url?scp=3142711532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3142711532&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-04-0143
DO - 10.1158/0008-5472.CAN-04-0143
M3 - Article
C2 - 15256468
AN - SCOPUS:3142711532
SN - 0008-5472
VL - 64
SP - 4950
EP - 4956
JO - Cancer research
JF - Cancer research
IS - 14
ER -